Everyone said ‘no’ to MindMed, now it’s worth $2 billion with ‘unicorn’ status

Click here to get this article in PDF

MindMed (MMED.NE) has gone beyond the $2 billion market cap on Monday when shares rose 35% by noontime. Year-to-date, the business's stock rose greater than 10 times, from 53 cents in March to $5.60 by the end of the trading day.

JR Rahn, founder and co-CEO informs his tale of taking this biotech from beginning to 'unicorn' condition in under 3 years.

0:00 – What is driving supply rise?
2:55 – Risks?
5:12 – Source of capital flows
6:55 – Origins of MindMed
11:07 – Getting over rejection
13:13 – Development of market as well as future of MindMed
17:11 – Psychedelics are damaging?
__________________________________________________________________
Kitco Information is the world's # 1 source of steels market info. Our video clips include meetings with prominent industry figures to bring you market-affecting insights, with the goal helpful individuals make informed financial investment choices.

Register for our network to keep up to day on the most up to date insights moving the metals markets.

For even more breaking information, check out

Follow us on social networks:
Facebook –
Twitter –
Google+:.
StockTwits -.

Real-time gold rate as well as graphes:.
Live silver price and graphes:.

Don't forget to register for Kitco Information' Weekly Roundup– comes out every Friday to recap the hottest tales & video clips of the week:.

Sign up with the conversation @ The Kitco Forums and also be part of the premier on-line neighborhood for precious metals investors:.

Please note: Video clips are not trading recommendations and the sights expressed may not reflect those of Kitco Metals Inc
.